NIM
BSX icon

NEOS Investment Management’s Boston Scientific BSX Stock Holding History

NEOS Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
243,837
+23,291
+11% +$1.26M 0.04% 265
2026
Q1 		$13.8M Sell
220,546
-6,638
-3% -$531K 0.07% 198
2025
Q4 		$21.7M Buy
227,184
+33,404
+17% +$3.27M 0.13% 139
2025
Q3 		$18.9M Buy
193,780
+58,819
+44% +$6.09M 0.14% 132
2025
Q2 		$14.5M Buy
134,961
+8,075
+6% +$817K 0.18% 110
2025
Q1 		$12.8M Buy
126,886
+18,129
+17% +$1.83M 0.24% 82
2024
Q4 		$9.71M Buy
108,757
+15,325
+16% +$1.35M 0.23% 86
2024
Q3 		$7.83M Buy
93,432
+13,796
+17% +$1.09M 0.24% 84
2024
Q2 		$6.13M Buy
79,636
+22,384
+39% +$1.64M 0.25% 74
2024
Q1 		$3.92M Buy
57,252
+29,430
+106% +$1.89M 0.24% 82
2023
Q4 		$1.61M Buy
27,822
+12,933
+87% +$690K 0.15% 136
2023
Q3 		$786K Buy
+14,889
New +$781K 0.1% 168

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NEOS Investment Management's BSX Position: Q2 2026 in Review

NEOS Investment Management increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $1.26M and bringing the position to 243,837 shares worth $10.4M. The position accounts for 0.04% of the portfolio, ranked #265.

NEOS Investment Management first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $21.7M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • NEOS Investment Management held 243,837 shares of Boston Scientific worth $10.4M as of Q2 2026.
  • NEOS Investment Management bought 23,291 Boston Scientific shares in Q2 2026, an estimated $1.26M.
  • Boston Scientific made up 0.04% of NEOS Investment Management's portfolio in Q2 2026, its #265 holding.
  • NEOS Investment Management first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's Boston Scientific position peaked at $21.7M in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.